+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children



Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children



Monaldi Archives for Chest Disease 67(1): 30-38



Compliance with long-term inhaled therapy in asthma is often poor, but it is likely to be improved with a simplified administration, once daily. The present study was designed to assess whether, in childhood asthma, a single dose of nebulized beclomethasone dipropionate once daily was as effective and safe as the same total daily dose administered twice daily. Asthmatic children, not treated with inhaled steroids for at least a month preceding the study and using short-acting bronchodilators more than once a week were enrolled in a double-blind, double dummy, randomised, multicentric study. After a two week run-in period on nebulised twice daily 400 mcg beclomethasone dipropionate, patients were randomly assigned to twelve weeks of treatment with 800 mcg nebulised beclomethasone dipropionate daily, either in single dose (o.d. group) or divided into two 400 mcg doses (b.i.d. group). 65 children (mean age 8.6 years, mean FEV1 81% of predicted), were valuable for intention to treat. During the run-in period, a significant improvement in FEV1, FVC, morning and evening PEF values and clinical scores was observed. Children then entered the randomised trial: 32 were included in the o.d. group and 33 in the b.i.d. group. During the twelve week treatment period, the observed improvement in pulmonary function parameters was maintained in both treatment groups. Morning and evening PEF showed a progressive slight increase as well as PEF diurnal variability showed a progressive reduction in the two treatment groups during the whole study period without reaching statistical significance. Moreover, in both treatment groups a similar progressive increase in symptom free nights and days and in the percentage of children achieving total asthma symptoms control was detected. Finally, no significant changes in urinary cortisol/creatinine ratio were observed throughout the study period and between groups. A daily dose of 800 mcg of beclomethasone, administered for twelve weeks with a nebuliser either once or twice daily provide similar efficacy in maintaining pulmonary function and symptoms of asthmatic children, with a good tolerability profile.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054743871

Download citation: RISBibTeXText

PMID: 17564282

DOI: 10.4081/monaldi.2007.507


Related references

Comparison of quality of life and pulmonary function on moderate asthmatic children treated with beclomethasone and beclomethasone plus salmeterol. Journal of Allergy & Clinical Immunology 107(2): S263, 2001

Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. Annals of Allergy, Asthma and Immunology 86(6): 633-640, 2001

Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children. Arerugi 56(12): 1502-1509, 2008

Jet-nebulized beclomethasone dipropionate in the management of bronchial asthma. Topical steroids for asthmatic children younger than 4 years. Allergy 42(4): 272-275, 1987

Therapy with nebulized beta2 agonists (procaterol) in asthmatic children: pulmonary function and plasma levels after inhalation. Arerugi 56(11): 1372-1377, 2007

Fluticasone propionate given once daily is as effective as beclomethasone dipropionate given twice daily in relieving symptoms of seasonal allergic rhinitis. Journal of Allergy & Clinical Immunology 85(1 PART 2): 163, 1990

Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax 48(4): 309-316, 1993

HFA-beclomethasone dipropionate is effective at improving asthma at doses as low as 50mcg twice daily. Journal of Allergy & Clinical Immunology 101(1 PART 2): S64, 1998

Heterogeneity of daily pulmonary function in response to air pollution among asthmatic children. Southeast Asian Journal of Tropical Medicine and Public Health 35(4): 990-998, 2005

Reduction of oral steroids and improvement in adrenal function in asthmatic subjects taking 2000 mug of inhaled beclomethasone daily. Journal of Allergy & Clinical Immunology 79(1): 202, 1987

Efficacy of nebulized metaproterenol in improving symptoms of children with rsv bronchiolitis. American Journal of Diseases of Children 144(4): 444, 1990

Effect of beclomethasone increment on airflow limitation in asthmatic children treated with high dose beclomethasone. Arerugi 49(4): 345-351, 2000

Comparison of inhaled beclomethasone dipropionate 1000 micrograms twice daily and oral prednisone 10 mg once daily in asthmatic patients. Thorax 49(1): 37-40, 1994

Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. Respiratory Medicine 99(11): 1418-1424, 2005

Effect of inhaled nedocromil sodium therapy on blood gas changes in asthmatic children challenged with ultrasonically nebulized distilled water A comparison of 8 mg versus 16 mg daily dose. Mediators of Inflammation 3(SUPPL 1): S49-S50, 1994